Discrete SARS-CoV-2 antibody titers track with functional humoral stability

• Published in: Nature communications Vol. 12; no. 1; pp. 1018 - 8
• Main Authors: Bartsch, Yannic C., Fischinger, Stephanie, Siddiqui, Sameed M., Chen, Zhilin, Yu, Jingyou, Gebre, Makda, Atyeo, Caroline, Gorman, Matthew J., Zhu, Alex Lee, Kang, Jaewon, Burke, John S., Slein, Matthew, Gluck, Matthew J., Beger, Samuel, Hu, Yiyuan, Rhee, Justin, Petersen, Eric, Mormann, Benjamin, Aubin, Michael de St, Hasdianda, Mohammad A., Jambaulikar, Guruprasad, Boyer, Edward W., Sabeti, Pardis C., Barouch, Dan H., Julg, Boris D., Musk, Elon R., Menon, Anil S., Lauffenburger, Douglas A., Nilles, Eric J., Alter, Galit
• Format: Journal Article
• Language: English
• Published: London Nature Publishing Group UK 15.02.2021; Nature Publishing Group; Nature Portfolio
• Subjects: 13/1; 13/109; 13/31; 14; 49; 49/1; 631/250/2152/2153/1291; 631/250/255/2514; Adolescent; Adult; Aged; Antibodies; Antibodies, Neutralizing - blood; Antibodies, Neutralizing - immunology; Antibodies, Viral - blood; Antibodies, Viral - immunology; Asymptomatic infection; Binding; Biomarkers; Coronaviruses; COVID-19; COVID-19 - blood; COVID-19 - immunology; Female; Heterogeneity; Humanities and Social Sciences; Humans; Humoral immunity; Immunity; Immunity, Humoral - immunology; Immunoglobulin G - immunology; Infections; Lymphocytes; Lymphocytes T; Male; Middle Aged; multidisciplinary; Neutralization; SARS-CoV-2 - immunology; Science; Science (multidisciplinary); Severe acute respiratory syndrome coronavirus 2; Spike Glycoprotein, Coronavirus - immunology; T-Lymphocytes - immunology; Vaccines; Viral Vaccines - immunology; Young Adult
• ISSN: 2041-1723; 2041-1723
• DOI: 10.1038/s41467-021-21336-8

Antibodies serve as biomarkers of infection, but if sustained can confer long-term immunity. Yet, for most clinically approved vaccines, binding antibody titers only serve as a surrogate of protection. Instead, the ability of vaccine induced antibodies to neutralize or mediate Fc-effector functions is mechanistically linked to protection. While evidence has begun to point to persisting antibody responses among SARS-CoV-2 infected individuals, cases of re-infection have begun to emerge, calling the protective nature of humoral immunity against this highly infectious pathogen into question. Using a community-based surveillance study, we aimed to define the relationship between titers and functional antibody activity to SARS-CoV-2 over time. Here we report significant heterogeneity, but limited decay, across antibody titers amongst 120 identified seroconverters, most of whom had asymptomatic infection. Notably, neutralization, Fc-function, and SARS-CoV-2 specific T cell responses were only observed in subjects that elicited RBD-specific antibody titers above a threshold. The findings point to a switch-like relationship between observed antibody titer and function, where a distinct threshold of activity—defined by the level of antibodies—is required to elicit vigorous humoral and cellular response. This response activity level may be essential for durable protection, potentially explaining why re-infections occur with SARS-CoV-2 and other common coronaviruses. The extent of antibody protection against SARS-CoV-2 remains unclear. Here, using a cohort of 120 seroconverted individuals, the authors longitudinally characterize neutralization, Fc-function, and SARS-CoV-2 specific T cell responses, which they show to be prominent only in those subjects that elicited receptor-binding domain (RBD)-specific antibody titers above a certain threshold, suggesting that development of T cell responses to be related to anti-RBD Ab production.